Mexico - Delayed Quote MXN

Ocugen, Inc. (OCGN.MX)

Compare
13.35
0.00
(0.00%)
At close: February 25 at 1:19:14 PM CST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,700
6,036
2,488
--
43
Operating Expense
57,142
71,567
91,559
58,028
14,328
Operating Income
-52,442
-65,531
-89,071
-58,028
-14,285
Net Non Operating Interest Income Expense
--
--
--
-79
-721
Other Income Expense
1,298
2,453
2,267
-389
-6,816
Pretax Income
-51,144
-63,078
-86,804
-58,417
-21,822
Tax Provision
--
--
--
-52
--
Net Income Common Stockholders
-51,144
-63,078
-86,804
-58,365
-34,368
Diluted NI Available to Com Stockholders
-51,144
-63,078
-86,804
-58,365
-34,368
Basic EPS
-0.19
-0.26
-0.38
-0.30
-0.31
Diluted EPS
-0.19
-0.26
-0.38
-0.30
-0.31
Basic Average Shares
262,387.68
244,327.06
214,600.05
195,013.04
112,236.11
Diluted Average Shares
262,387.68
244,327.06
214,600.05
195,013.04
112,236.11
Total Operating Income as Reported
-52,442
-65,531
-89,071
-58,028
-21,285
Total Expenses
57,142
71,567
91,559
58,028
14,328
Net Income from Continuing & Discontinued Operation
-51,144
-63,078
-86,804
-58,365
-21,822
Normalized Income
-51,144
-63,078
-86,804
-58,365
-14,822
Interest Income
--
--
--
--
1.07
Interest Expense
--
--
--
79
721
Net Interest Income
--
--
--
-79
-721
EBIT
-52,442
-65,531
-89,071
-58,028
-21,101
EBITDA
-50,893
-64,827
-88,591
-57,799
-20,999
Reconciled Depreciation
1,549
704
480
229
102
Net Income from Continuing Operation Net Minority Interest
-51,144
-63,078
-86,804
-58,365
-21,822
Total Unusual Items Excluding Goodwill
--
--
--
--
-7,000
Total Unusual Items
--
--
--
--
-7,000
Normalized EBITDA
-50,893
-64,827
-88,591
-57,799
-13,999
Tax Rate for Calcs
--
--
--
0
--
12/31/2020 - 6/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INO.MX Inovio Pharmaceuticals, Inc.
40.00
0.00%
 
ATOS.MX Atossa Therapeutics, Inc.
14.70
-8.13%
 
NRSNW NeuroSense Therapeutics Ltd.
0.1531
-23.45%
 
MRNA.MX Moderna, Inc.
624.80
+0.29%
 
ENTO Entero Therapeutics, Inc.
0.6100
+23.31%
 
NRSN NeuroSense Therapeutics Ltd.
1.0500
-4.11%
 
ITRM Iterum Therapeutics plc
1.3300
-4.66%
 
ATOS Atossa Therapeutics, Inc.
0.7410
-3.23%
 
SLS SELLAS Life Sciences Group, Inc.
1.1600
-1.69%
 
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%